An Educational Overview — Not a Prescription Pathway
Vyvanse for ADHD: Who It May Help and What to Expect
Vyvanse is an FDA-approved ADHD medication with real benefits and real risks. Learn how it works, what monitoring involves, and how our psychiatrists determine whether it's the right option — starting with a comprehensive evaluation.
Most major insurance accepted • Self-pay options available
Request an ADHD Evaluation
Understanding Vyvanse for ADHD
Considering ADHD Treatment? Start With an Evaluation
Same-week ADHD evaluations available. ADHD symptoms can overlap with anxiety, depression, sleep disorders, and other conditions. A thorough psychiatric evaluation is the essential first step before any treatment decision — including whether medication is appropriate at all.
Empathy Health Clinic does not guarantee or promise controlled substances. All prescribing decisions are made after a comprehensive clinical evaluation.
Vyvanse (lisdexamfetamine dimesylate) is an FDA-approved medication used to treat attention-deficit/hyperactivity disorder (ADHD) in adults and children ages 6 and older. It is a Schedule II controlled substance and a central nervous system (CNS) stimulant, meaning it has a recognized medical use but also carries risks that require careful clinical oversight.
This page is designed to help you understand what Vyvanse is, how it works, what the risks are, and what treatment and monitoring look like — so you can have an informed conversation with your psychiatrist. This is an educational resource, not a prescription pathway. Whether Vyvanse or any other ADHD medication is appropriate for you depends entirely on the results of your clinical evaluation.
At Empathy Health Clinic, our ADHD psychiatrists in Orlando follow a comprehensive evaluation-first process. We assess for ADHD using clinical interview, symptom history, and differential diagnosis — ruling out conditions like anxiety, depression, bipolar disorder, and sleep disorders that can mimic ADHD symptoms. Only after a confirmed diagnosis and thorough risk assessment do we discuss medication options.
FDA Boxed Warning — Vyvanse (lisdexamfetamine)
Vyvanse carries a boxed warning — the most serious type of FDA warning — stating:
- • CNS stimulants, including Vyvanse, have a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction
- • Misuse of CNS stimulants can cause sudden death, stroke, and myocardial infarction (heart attack)
- • Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence during treatment
This warning is provided verbatim from FDA labeling for educational purposes. It is not intended to discourage treatment when clinically appropriate — it is intended to emphasize that stimulant prescribing requires careful clinical judgment, risk assessment, and ongoing monitoring.
Evaluation-First Process
Comprehensive ADHD assessment including differential diagnosis before any medication decision
Board-Certified Psychiatrists
ADHD care from experienced psychiatric providers, not primary care or telehealth mills
Ongoing Monitoring
Regular follow-ups to assess effectiveness, side effects, and safe use
Risk Assessment
Careful screening for substance use history, cardiovascular risk, and other contraindications
Non-Stimulant Options Available
Alternatives like Strattera, Intuniv, and Wellbutrin when stimulants aren't appropriate
Same-Week Appointments
Quick access to ADHD evaluation with in-person and telehealth options
What You Need to Know About Vyvanse
How it works, who it may help, and what responsible prescribing looks like
How Vyvanse Works
Vyvanse is a prodrug — meaning it is inactive until metabolized in the body, where it converts to dextroamphetamine. This prodrug design results in a gradual onset and extended duration (up to 14 hours), reducing the 'peak and crash' pattern seen with some other stimulants. It increases dopamine and norepinephrine in the brain, which helps with focus, attention, and impulse control.
Who Vyvanse May Help
Vyvanse may be appropriate for adults with a confirmed ADHD diagnosis who have been evaluated for co-occurring conditions and substance use risk. It is typically considered when the clinical evaluation supports a stimulant trial and the patient's risk profile is acceptable. It is not appropriate for everyone with ADHD — your psychiatrist determines candidacy.
What the Evaluation Involves
Before prescribing any stimulant, our psychiatrists conduct a comprehensive clinical evaluation: detailed symptom history, ADHD rating scales, differential diagnosis (anxiety, depression, bipolar, sleep disorders), substance use screening, cardiovascular risk review, and assessment of past medication response. This typically takes 45–90 minutes.
What Monitoring Looks Like
Patients on Vyvanse are monitored with regular follow-up appointments (typically monthly). Monitoring includes: symptom response assessment, side effect review, vital signs (blood pressure, heart rate), weight tracking, sleep quality check, and assessment for signs of misuse or diversion. Dose adjustments are made as needed.
Common Side Effects
Common side effects include decreased appetite, dry mouth, insomnia, increased heart rate, and irritability. Less common but important effects include elevated blood pressure, anxiety, and mood changes. Most side effects are dose-related and can be managed with dosage adjustments or timing changes. Your psychiatrist will discuss what to watch for.
Safe Storage and Handling
As a Schedule II controlled substance, Vyvanse should be stored securely and never shared with others. Patients are counseled on safe storage, especially in households with other individuals. Lost or stolen medication reports are documented. These are standard controlled substance safety practices, not signs of distrust.
Insurance & Payment Options
We accept most major insurance plans and offer flexible payment options
Find an in-network provider from most insurance plans
Add your insurance to see in-network mental health providers
We accept most major commercial insurance plans for ADHD evaluation and medication management. Self-pay options available. Note: We do not accept Medicaid or Sunshine Health.
Why Choose Empathy Health Clinic
Licensed Professionals
Board-certified psychiatrists and licensed therapists
HIPAA Compliant
Your privacy and confidentiality are protected
Insurance Accepted
We accept most major insurance plans
Same-Week Appointments
Fast access to care when you need it most
Our ADHD Evaluation Process
Before prescribing any ADHD medication, we follow a thorough evaluation process to ensure an accurate diagnosis and safe treatment plan.
Detailed discussion of current symptoms, onset timeline, impact on daily functioning, and symptom history across settings (work, relationships, daily tasks).
Screening for conditions that can mimic ADHD: anxiety disorders, depression, bipolar disorder, sleep disorders, thyroid conditions, and substance use effects on attention.
Review of cardiovascular history, blood pressure, substance use history, family history of heart problems, and personal/family history of addiction.
Discussion of all options — behavioral strategies, stimulant medications (Vyvanse), non-stimulant medications, or combined approaches — with clear explanation of benefits, risks, and monitoring requirements.
Before starting any controlled substance, patients receive clear information about risks, expectations, monitoring schedule, and safe use practices.
Vyvanse vs Non-Stimulant ADHD Medications
Not every ADHD patient is a candidate for stimulant medication. Understanding both pathways helps you have a more productive conversation with your psychiatrist.
Vyvanse (Stimulant)
- • Rapid onset (1–2 hours), up to 14-hour duration
- • Strong evidence base for core ADHD symptoms
- • Prodrug design reduces abuse potential vs some stimulants
- • Schedule II controlled substance — monitoring required
- • Not recommended with active substance use disorder
- • Cardiovascular screening needed
Non-Stimulant Options
- • No abuse potential — not controlled substances
- • Safer for patients with substance use history
- • May be preferred with significant anxiety or tics
- • Slower onset (weeks to full effect)
- • Options: Strattera, Intuniv, Wellbutrin
- • Less cardiovascular concern
Important Safety Information
Vyvanse is a Schedule II controlled substance with a recognized potential for abuse, misuse, and addiction. Our clinic takes this seriously and follows responsible prescribing practices aligned with FDA guidance and clinical best practices.
Before prescribing: We assess every patient's risk for substance use disorder, cardiovascular disease, psychiatric comorbidities, and other contraindications. Patients with active, untreated substance use disorders are generally not candidates for stimulant medications — non-stimulant alternatives are available and effective.
During treatment: All patients on Vyvanse receive regular monitoring including vital signs, symptom assessment, side effect review, and screening for misuse. Dose adjustments are made based on clinical response. Prescriptions are not refilled without follow-up appointments.
Contraindications: Vyvanse should not be taken by individuals with known hypersensitivity to amphetamine products, those taking MAO inhibitors, or those with certain cardiovascular conditions. A full medical and psychiatric history is required before prescribing.
This page is for educational purposes only. It does not constitute medical advice, a diagnosis, or a guarantee of treatment. Empathy Health Clinic does not sell or advertise prescription drugs online. All treatment requires a clinical evaluation.
Related Services & Resources
Medical References
This page is for educational purposes only and does not constitute medical advice, a prescription, or a guarantee of treatment. Vyvanse is a Schedule II controlled substance with serious risks including abuse, misuse, addiction, and cardiovascular events. All treatment requires a comprehensive clinical evaluation. Empathy Health Clinic does not sell or advertise prescription drugs online.
Verified On
Vyvanse & ADHD Treatment FAQs
Get a Thorough ADHD Evaluation
The right ADHD treatment starts with the right diagnosis. Our psychiatrists take the time to evaluate your symptoms, rule out other conditions, and recommend the safest, most effective approach for you.